Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Top of the News-lir
Subscribe today for access to
Articles and Reports
Getting Started with the FDA’s New LDT Rule
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.
Transitioning the Clinical Lab
What clinical laboratory professionals need to know about healthcare provision for transgender and nonbinary patients
Quest’s Free iPad-Based Cognitive Evaluation Test Aids Physicians
From - Laboratory Industry Report
Quest Diagnostics has introduced a product that is a departure from the typical laboratory test but is expected to assist…
LabCorp Strikes Deal to Acquire Sequenom
From - Laboratory Industry Report
LabCorp has entered into another big deal, coming to terms to acquire neonatal specialty lab Sequenom for…
LabCorp Snaps Up a Momentarily Distressed Sequenom
...
Already a member? Log in here
LabCorp, Quest Post Big Earnings Growth through First Half of Year
...
Already a member? Log in here
Quest Launches Free iPad-Based Cognitive Evaluation Test
...
Already a member? Log in here
Trovagene and USC Collaborate on Liquid Biopsy Test
From - Laboratory Industry Report
Trovagene, the San Diego-based molecular laboratory, has entered into a deal with the University of Southern California's Norris Comprehensive Cancer Center to collaborate on creating a…
LabFinder Helps Connects Patients and Laboratories
From - Laboratory Industry Report
A New York City physician has started up a business that aims to be a price and services clearinghouse and records depository for patients wishing to…
LABS Undergoes Extensive Rebranding Effort
...
Already a member? Log in here
FDA Issues Guidelines on NGS-Based Tests
...
Already a member? Log in here
Trovagene Enters Into Pact With USC on Liquid Biopsy Test
...
Already a member? Log in here